Plant ID: NPO520
Plant Latin Name: Euphorbia lathyris
Taxonomy Genus: Euphorbia
Taxonomy Family: Euphorbiaceae
NCBI TaxonomyDB:
212925
Plant-of-the-World-Online:
347072-1
Abortifacient; Antiseptic; Cancer; Diuretic; Emetic; Purgative; Warts
Brazil; Italy; France; Ethiopia; Argentina; Bolivia; Venezuela; China; Chile; Belgium; Germany; Spain; United States; Morocco; Vietnam; New Zealand; Russia; Pakistan; Albania; Portugal; Mexico; Uruguay; India; United Kingdom
TDP1; HPGD; HSD17B10; ALOX15; ALDH1A1; | |
PRKCD; EGFR; LCK; FYN; | |
CA2; CA1; CA12; CA9; CA14; CA5B; CA5A; CA3; CA7; CA6; | |
THRB; | |
KDM4E; | |
CASP1; CASP7; | |
HIF1A; | |
LMNA; | |
XDH; |
Cytochrome P450 Enzymes: | CYP2D6; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cysteine protease | CASP1 | Caspase-1 | P29466 | CHEMBL4801 |
Cysteine protease | CASP7 | Caspase-7 | P55210 | CHEMBL3468 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | HPGD | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | CHEMBL1293255 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Lyase | CA5B | Carbonic anhydrase VB | Q9Y2D0 | CHEMBL3969 |
Lyase | CA5A | Carbonic anhydrase VA | P35218 | CHEMBL4789 |
Lyase | CA3 | Carbonic anhydrase III | P07451 | CHEMBL2885 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Lysine demethylase | KDM4E | Lysine-specific demethylase 4D-like | B2RXH2 | CHEMBL1293226 |
Nuclear hormone receptor subfamily 1 group A | THRB | Thyroid hormone receptor beta-1 | P10828 | CHEMBL1947 |
Oxidoreductase | XDH | Xanthine dehydrogenase | P47989 | CHEMBL1929 |
Protein Kinase | PRKCD | Protein kinase C delta | Q05655 | CHEMBL2996 |
Protein Kinase | EGFR | Epidermal growth factor receptor erbB1 | P00533 | CHEMBL203 |
Protein Kinase | LCK | Tyrosine-protein kinase LCK | P06239 | CHEMBL258 |
Protein Kinase | FYN | Tyrosine-protein kinase FYN | P06241 | CHEMBL1841 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 7.259E-08 | 1.216E-04 | CA1, CA12, CA2, CA3, CA5A, CA5B, CA6, CA7, CA9, THRB |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 1.269E-26 | 2.764E-22 | CA1, CA12, CA14, CA2, CA3, CA5A, CA5B, CA6, CA7, CA9 |
MF | GO:0005488; binding | GO:0042610; CD8 receptor binding | 1.882E-06 | 2.410E-03 | FYN, LCK |
BP | GO:0065007; biological regulation | GO:0006919; activation of cysteine-type endopeptidase activity involved in apoptotic process | 4.914E-06 | 5.223E-03 | CASP1, CASP7, LCK, XDH |
BP | GO:0050896; response to stimulus | GO:0042493; response to drug | 5.037E-06 | 5.223E-03 | CA3, CA9, CASP1, EGFR, FYN, HPGD, LCK, PRKCD |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 5.640E-06 | 5.500E-03 | CA2, CA7 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 1.025E-20 | 1.116E-16 | CA1, CA12, CA14, CA2, CA3, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 4.189E-19 | 2.281E-15 | CA1, CA12, CA2, CA3, CA5A, CA5B, CA6, CA7, CA9 |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 2.813E-05 | 1.856E-02 | CA1, CA2 |
MF | GO:0005488; binding | GO:0042609; CD4 receptor binding | 3.934E-05 | 2.225E-02 | FYN, LCK |
CC | GO:0016020; membrane | GO:0016323; basolateral plasma membrane | 1.228E-04 | 4.776E-02 | CA2, CA9, EGFR, HPGD |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 5.796E-26 | 5.448E-24 | CA12, CA1, CA3, CA5B, CA2, CA5A, CA7, CA6, CA9, CA14 |
09160 Human Diseases | 09167 Infectious diseases | hsa05134 | Legionellosis | 2.494E-03 | 7.380E-02 | CASP7, CASP1 |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 3.676E-03 | 7.380E-02 | HIF1A, EGFR |
09140 Cellular Processes | 09144 Cellular community - eukaryotes | hsa04520 | Adherens junction | 4.465E-03 | 7.380E-02 | FYN, EGFR |
09150 Organismal Systems | 09152 Endocrine system | hsa04912 | GnRH signaling pathway | 6.675E-03 | 7.380E-02 | PRKCD, EGFR |
09160 Human Diseases | 09167 Infectious diseases | hsa05133 | Pertussis | 4.583E-03 | 7.380E-02 | CASP7, CASP1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04915 | Estrogen signaling pathway | 7.855E-03 | 7.380E-02 | PRKCD, EGFR |
09160 Human Diseases | 09161 Cancers | hsa05231 | Choline metabolism in cancer | 8.163E-03 | 7.380E-02 | HIF1A, EGFR |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04066 | HIF-1 signaling pathway | 8.477E-03 | 7.380E-02 | HIF1A, EGFR |
09150 Organismal Systems | 09151 Immune system | hsa04660 | T cell receptor signaling pathway | 8.636E-03 | 7.380E-02 | LCK, FYN |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9; |
I00-I99: Diseases of the circulatory system | Acute myocardial infarction | I21-I22 | PRKCD; |
C00-D49: Neoplasms | Renal cancer | C64 | CA9; |
C00-D49: Neoplasms | Cancer | C00-C96 | CA9; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9; |
C00-D49: Neoplasms | Breast cancer | C50 | CA9; |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9; |
NA: NA | Reperfusion injury and heart attacks | NA | PRKCD; |